← Back to Search

Behavioural Intervention

The Donor App for Kidney Failure

N/A
Recruiting
Led By Andrew Cameron, MD PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
On the kidney-only or liver-only transplant waiting list at a collaborating center
Must not have
Younger than 18 years of age
Not on the kidney or liver transplant waiting list
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial uses a web app to help transplant patients on a waitlist communicate their need for a living donor, and provides potential donors the opportunity to engage with the evaluation process.

Who is the study for?
This trial is for adults over 18 who are on the waiting list for a kidney or liver transplant at a participating center. It's not open to those under 18, not on the transplant waitlist, or waiting for multiple organ transplants.
What is being tested?
The study is testing 'The Donor App', which is designed to help patients in need of an organ transplant use social media to find living donors and allows potential donors to start the evaluation process.
What are the potential side effects?
Since this trial involves using a web-based application rather than medical treatment, there are no direct physical side effects associated with traditional clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am on the waiting list for a kidney or liver transplant at a participating center.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I am not waiting for a kidney or liver transplant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Live donor transplantation
Potential donors identified
Secondary study objectives
App utilization as assessed by number of participants with story completion and posting in the donor app
The Donor App Implementation

Trial Design

1Treatment groups
Experimental Treatment
Group I: The Donor AppExperimental Treatment1 Intervention
Select physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterOTHER
431 Previous Clinical Trials
157,401 Total Patients Enrolled
Scripps HealthOTHER
56 Previous Clinical Trials
42,493 Total Patients Enrolled
Yale UniversityOTHER
1,907 Previous Clinical Trials
3,018,049 Total Patients Enrolled

Media Library

The Donor App (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03803423 — N/A
Liver Disease Research Study Groups: The Donor App
Liver Disease Clinical Trial 2023: The Donor App Highlights & Side Effects. Trial Name: NCT03803423 — N/A
The Donor App (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03803423 — N/A
~24 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top